Big Pharma is an underperforming sector of the stock market, but AbbVie’s 1yr and 5yr share price gains are second only to Eli Lilly.
( read original story …)
The SkinCare Site
Big Pharma is an underperforming sector of the stock market, but AbbVie’s 1yr and 5yr share price gains are second only to Eli Lilly.
( read original story …)